Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

InspireMD (NSPR) Cash from Investing Activities (2016 - 2025)

InspireMD (NSPR) has 16 years of Cash from Investing Activities data on record, last reported at $7.6 million in Q3 2025.

  • For Q3 2025, Cash from Investing Activities rose 227.46% year-over-year to $7.6 million; the TTM value through Sep 2025 reached $22.8 million, up 422.97%, while the annual FY2024 figure was $12.6 million, 178.55% up from the prior year.
  • Cash from Investing Activities reached $7.6 million in Q3 2025 per NSPR's latest filing, up from $5.3 million in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at $8.2 million in Q4 2024 and bottomed at -$26.9 million in Q2 2023.
  • Average Cash from Investing Activities over 5 years is -$152210.5, with a median of $1.9 million recorded in 2022.
  • Peak YoY movement for Cash from Investing Activities: plummeted 49255.1% in 2021, then soared 22994.44% in 2024.
  • A 5-year view of Cash from Investing Activities shows it stood at $1.8 million in 2021, then skyrocketed by 111.08% to $3.9 million in 2022, then tumbled by 100.93% to -$36000.0 in 2023, then skyrocketed by 22994.44% to $8.2 million in 2024, then dropped by 8.38% to $7.6 million in 2025.
  • Per Business Quant database, its latest 3 readings for Cash from Investing Activities were $7.6 million in Q3 2025, $5.3 million in Q2 2025, and $1.7 million in Q1 2025.